212 related articles for article (PubMed ID: 24410848)
1. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
Domingo L; Salas D; Zubizarreta R; Baré M; Sarriugarte G; Barata T; Ibáñez J; Blanch J; Puig-Vives M; Fernández A; Castells X; Sala M;
Breast Cancer Res; 2014 Jan; 16(1):R3. PubMed ID: 24410848
[TBL] [Abstract][Full Text] [Related]
2. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
[TBL] [Abstract][Full Text] [Related]
3. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
5. Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer.
Sartor H; Zackrisson S; Elebro K; Hartman L; Borgquist S
Cancer Causes Control; 2015 Jun; 26(6):931-9. PubMed ID: 25860114
[TBL] [Abstract][Full Text] [Related]
6. Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers.
Sala M; Domingo L; Louro J; Torá-Rocamora I; Baré M; Ferrer J; Carmona-Garcia MC; Barata T; Román M; Macià F; Castells X;
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):908-916. PubMed ID: 29853482
[No Abstract] [Full Text] [Related]
7. Relationship of established risk factors with breast cancer subtypes.
McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
[TBL] [Abstract][Full Text] [Related]
8. Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.
Holloway CMB; Jiang L; Whitehead M; Racz JM; Groome PA
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1769-1775. PubMed ID: 29909564
[TBL] [Abstract][Full Text] [Related]
9. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms.
Bae MS; Han W; Koo HR; Cho N; Chang JM; Yi A; Park IA; Noh DY; Choi WS; Moon WK
Cancer Sci; 2011 Oct; 102(10):1862-7. PubMed ID: 21752153
[TBL] [Abstract][Full Text] [Related]
11. Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme.
Blanch J; Sala M; Ibáñez J; Domingo L; Fernandez B; Otegi A; Barata T; Zubizarreta R; Ferrer J; Castells X; Rué M; Salas D;
PLoS One; 2014; 9(10):e110207. PubMed ID: 25333936
[TBL] [Abstract][Full Text] [Related]
12. Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening.
Caldarella A; Puliti D; Crocetti E; Bianchi S; Vezzosi V; Apicella P; Biancalani M; Giannini A; Urso C; Zolfanelli F; Paci E
J Cancer Res Clin Oncol; 2013 Feb; 139(2):181-5. PubMed ID: 22961208
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density and risk of breast cancer by age and tumor characteristics.
Bertrand KA; Tamimi RM; Scott CG; Jensen MR; Pankratz V; Visscher D; Norman A; Couch F; Shepherd J; Fan B; Chen YY; Ma L; Beck AH; Cummings SR; Kerlikowske K; Vachon CM
Breast Cancer Res; 2013 Nov; 15(6):R104. PubMed ID: 24188089
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.
Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI
Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain.
Domingo L; Sala M; Servitja S; Corominas JM; Ferrer F; Martínez J; Macià F; Quintana MJ; Albanell J; Castells X
Cancer Causes Control; 2010 Aug; 21(8):1155-64. PubMed ID: 20349271
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Mammographic Density Measurements and Molecular Subtypes in Chinese Women With Breast Cancer.
Tian Y; Guida JL; Koka H; Li EN; Zhu B; Sung H; Chan A; Zhang H; Tang E; Guo C; Deng J; Hu N; Lu N; Gierach GL; Li J; Yang XR
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 34651101
[TBL] [Abstract][Full Text] [Related]
17. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
Roubidoux MA; Bailey JE; Wray LA; Helvie MA
Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
[TBL] [Abstract][Full Text] [Related]
18. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
19. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
Parise C; Caggiano V
Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
[TBL] [Abstract][Full Text] [Related]
20. Higher Detection Rates of Biologically Aggressive Breast Cancers in Mammography Screening than in the Biennial Interval.
Prange A; Bokhof B; Polzer P; Tio J; Radke I; Heidinger O; Heindel W; Weigel S
Rofo; 2019 Feb; 191(2):130-136. PubMed ID: 30103233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
